Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Identification
- Display Name:
- Fatty acids, C16-18 (even numbered), reaction products with tetraethylenepentamine
- Molecular formula:
- not applicable (UVCB substance)
- IUPAC Name:
- Fatty acids, C16-18 (even numbered), reaction products with tetraethylenepentamine
Type of Substance
- Composition:
- UVCB
- Origin:
- organic
Substance Identifiers
Compositions
Boundary Composition(s) open all close all
- State Form:
- other: solid: pellets
Constituent 1
- Reference substance name:
- N-[2-(4-{2-[(2-aminoethyl)amino]ethyl}piperazin-1-yl)ethyl]hexadecanamide N-[2-(4-{2-[(2-aminoethyl)amino]ethyl}piperazin-1-yl)ethyl]octadecanamide
- Molecular formula:
- C26H55N5O C28H59N5O
- IUPAC Name:
- N-[2-(4-{2-[(2-aminoethyl)amino]ethyl}piperazin-1-yl)ethyl]hexadecanamide N-[2-(4-{2-[(2-aminoethyl)amino]ethyl}piperazin-1-yl)ethyl]octadecanamide
Constituent 2
- Reference substance name:
- e.g. N-[2-(4-{2-[(2-hexadecanamidoethyl)amino]ethyl}piperazin-1-yl)ethyl]tetradecanamide
- Molecular formula:
- C40H81N5O2 C42H85N5O2 C44H89N5O2 C46H93N5O2 C48H97N5O2
- IUPAC Name:
- e.g. N-[2-(4-{2-[(2-hexadecanamidoethyl)amino]ethyl}piperazin-1-yl)ethyl]tetradecanamide
Constituent 3
- Reference substance name:
- e.g. N-[2-(4-{2-[(2-hexadecanamidoethyl)hexadecanoylamino]ethyl}piperazin-1-yl)ethyl]tetradecanamide
- Molecular formula:
- C58H115N5O3 C60H119N5O3 C62H123N5O3 C64H127N5O3
- IUPAC Name:
- e.g. N-[2-(4-{2-[(2-hexadecanamidoethyl)hexadecanoylamino]ethyl}piperazin-1-yl)ethyl]tetradecanamide
Constituent 4
- Reference substance name:
- e.g. N-(13-oxo-3,6,9,12-tetraazanonacosan-1-yl)hexadecanamide
- Molecular formula:
- C40H83N5O2 C42H87N5O2 C44H91N5O2
- IUPAC Name:
- e.g. N-(13-oxo-3,6,9,12-tetraazanonacosan-1-yl)hexadecanamide
Constituent 5
- Reference substance name:
- e.g. N-[2-({2-[bis(2-hexadecanamidoethyl)amino]ethyl}amino)ethyl]hexadecanamide
- Molecular formula:
- C56H113N5O3 C58H117N5O3 C60H121N5O3 C62H125N5O3
- IUPAC Name:
- e.g. N-[2-({2-[bis(2-hexadecanamidoethyl)amino]ethyl}amino)ethyl]hexadecanamide
Constituent 6
- Reference substance name:
- e.g. N-[2-(2-pentadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]-N-[2-(piperazin-1-yl)ethyl]hexadecanamide
- Molecular formula:
- C42H83N5O C44H87N5O C46H91N5O
- IUPAC Name:
- e.g. N-[2-(2-pentadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]-N-[2-(piperazin-1-yl)ethyl]hexadecanamide
Constituent 7
- Reference substance name:
- e.g. N-{2-[(2-{[2-(2-hexadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]amino}ethyl)amino]ethyl}hexadecanamide
- Molecular formula:
- C40H81N5 C42H85N5 C44H89N5
- IUPAC Name:
- e.g. N-{2-[(2-{[2-(2-hexadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]amino}ethyl)amino]ethyl}hexadecanamide
Constituent 8
- Reference substance name:
- e.g. N-{2-[(2-{[2-(2-hexadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]hexadecanoylamino}ethyl)amino]ethyl}hexadecanamide
- Molecular formula:
- C56H111N5O2 C58H115N5O2 C60H119N5O2 C62H123N5O2
- IUPAC Name:
- e.g. N-{2-[(2-{[2-(2-hexadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]hexadecanoylamino}ethyl)amino]ethyl}hexadecanamide
Constituent 9
- Reference substance name:
- e.g. 2-(piperazin-1-yl)-N-[2-(2-hexadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]ethan-1-amine
- Molecular formula:
- C26H53N5 C28H57N5
- IUPAC Name:
- e.g. 2-(piperazin-1-yl)-N-[2-(2-hexadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]ethan-1-amine
Constituent 10
- Reference substance name:
- e.g. N-(2-{4-[2-(piperazin-1-yl)ethyl]piperazin-1-yl}ethyl)hexadecanamide
- Molecular formula:
- C28H57N5O C30H61N5O
- IUPAC Name:
- e.g. N-(2-{4-[2-(piperazin-1-yl)ethyl]piperazin-1-yl}ethyl)hexadecanamide
Constituent 11
- Reference substance name:
- e.g. N,N-bis[2-(2-pentadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]amine
- Molecular formula:
- C40H79N5 C42H83N5 C44H87N5
- IUPAC Name:
- e.g. N,N-bis[2-(2-pentadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]amine
Constituent 12
- Reference substance name:
- e.g. N,N-bis[2-(2-pentadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]hexadecanamide
- Molecular formula:
- C56H109N5O C58H113N5O C60H117N5O C62H121N5O
- IUPAC Name:
- e.g. N,N-bis[2-(2-pentadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]hexadecanamide
Constituent 13
- Reference substance name:
- e.g. N-(2-{N-[2-({2-[N-(2-hexadecanamidoethyl)hexadecanamido]ethyl}amino)ethyl]hexadecanamido}ethyl)hexadecanamide
- Molecular formula:
- C72H143N5O4 C74H147N5O4 C76H151N5O4
- IUPAC Name:
- e.g. N-(2-{N-[2-({2-[N-(2-hexadecanamidoethyl)hexadecanamido]ethyl}amino)ethyl]hexadecanamido}ethyl)hexadecanamide
Constituent 14
- Reference substance name:
- e.g. N-{2-[(2-aminoethyl)(hexadecanoyl)amino]ethyl}hexadecanamide
- Molecular formula:
- C36H73N3O2 C38H77N3O2 C40H81N3O2
- IUPAC Name:
- e.g. N-{2-[(2-aminoethyl)(hexadecanoyl)amino]ethyl}hexadecanamide
Legal Entity Composition(s) open all close all
- State Form:
- other: solid: pellets
Constituent 1
- Reference substance name:
- Not applicable
- Molecular formula:
- Not applicable
- IUPAC Name:
- Not applicable
Constituent 2
- Reference substance name:
- N-[2-(4-{2-[(2-aminoethyl)amino]ethyl}piperazin-1-yl)ethyl]hexadecanamide N-[2-(4-{2-[(2-aminoethyl)amino]ethyl}piperazin-1-yl)ethyl]octadecanamide
- Molecular formula:
- C26H55N5O C28H59N5O
- IUPAC Name:
- N-[2-(4-{2-[(2-aminoethyl)amino]ethyl}piperazin-1-yl)ethyl]hexadecanamide N-[2-(4-{2-[(2-aminoethyl)amino]ethyl}piperazin-1-yl)ethyl]octadecanamide
Constituent 3
- Reference substance name:
- e.g. N-[2-(4-{2-[(2-hexadecanamidoethyl)amino]ethyl}piperazin-1-yl)ethyl]tetradecanamide
- Molecular formula:
- C40H81N5O2 C42H85N5O2 C44H89N5O2 C46H93N5O2 C48H97N5O2
- IUPAC Name:
- e.g. N-[2-(4-{2-[(2-hexadecanamidoethyl)amino]ethyl}piperazin-1-yl)ethyl]tetradecanamide
Constituent 4
- Reference substance name:
- e.g. N-[2-(4-{2-[(2-hexadecanamidoethyl)hexadecanoylamino]ethyl}piperazin-1-yl)ethyl]tetradecanamide
- Molecular formula:
- C58H115N5O3 C60H119N5O3 C62H123N5O3 C64H127N5O3
- IUPAC Name:
- e.g. N-[2-(4-{2-[(2-hexadecanamidoethyl)hexadecanoylamino]ethyl}piperazin-1-yl)ethyl]tetradecanamide
Constituent 5
- Reference substance name:
- e.g. N-(13-oxo-3,6,9,12-tetraazanonacosan-1-yl)hexadecanamide
- Molecular formula:
- C40H83N5O2 C42H87N5O2 C44H91N5O2
- IUPAC Name:
- e.g. N-(13-oxo-3,6,9,12-tetraazanonacosan-1-yl)hexadecanamide
Constituent 6
- Reference substance name:
- e.g. N-[2-({2-[bis(2-hexadecanamidoethyl)amino]ethyl}amino)ethyl]hexadecanamide
- Molecular formula:
- C56H113N5O3 C58H117N5O3 C60H121N5O3 C62H125N5O3
- IUPAC Name:
- e.g. N-[2-({2-[bis(2-hexadecanamidoethyl)amino]ethyl}amino)ethyl]hexadecanamide
Constituent 7
- Reference substance name:
- e.g. N-[2-(2-pentadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]-N-[2-(piperazin-1-yl)ethyl]hexadecanamide
- Molecular formula:
- C42H83N5O C44H87N5O C46H91N5O
- IUPAC Name:
- e.g. N-[2-(2-pentadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]-N-[2-(piperazin-1-yl)ethyl]hexadecanamide
Constituent 8
- Reference substance name:
- e.g. N-{2-[(2-{[2-(2-hexadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]amino}ethyl)amino]ethyl}hexadecanamide
- Molecular formula:
- C40H81N5 C42H85N5 C44H89N5
- IUPAC Name:
- e.g. N-{2-[(2-{[2-(2-hexadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]amino}ethyl)amino]ethyl}hexadecanamide
Constituent 9
- Reference substance name:
- e.g. N-{2-[(2-{[2-(2-hexadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]hexadecanoylamino}ethyl)amino]ethyl}hexadecanamide
- Molecular formula:
- C56H111N5O2 C58H115N5O2 C60H119N5O2 C62H123N5O2
- IUPAC Name:
- e.g. N-{2-[(2-{[2-(2-hexadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]hexadecanoylamino}ethyl)amino]ethyl}hexadecanamide
Constituent 10
- Reference substance name:
- e.g. 2-(piperazin-1-yl)-N-[2-(2-hexadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]ethan-1-amine
- Molecular formula:
- C26H53N5 C28H57N5
- IUPAC Name:
- e.g. 2-(piperazin-1-yl)-N-[2-(2-hexadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]ethan-1-amine
Constituent 11
- Reference substance name:
- e.g. N-(2-{4-[2-(piperazin-1-yl)ethyl]piperazin-1-yl}ethyl)hexadecanamide
- Molecular formula:
- C28H57N5O C30H61N5O
- IUPAC Name:
- e.g. N-(2-{4-[2-(piperazin-1-yl)ethyl]piperazin-1-yl}ethyl)hexadecanamide
Constituent 12
- Reference substance name:
- e.g. N,N-bis[2-(2-pentadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]amine
- Molecular formula:
- C40H79N5 C42H83N5 C44H87N5
- IUPAC Name:
- e.g. N,N-bis[2-(2-pentadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]amine
Constituent 13
- Reference substance name:
- e.g. N,N-bis[2-(2-pentadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]hexadecanamide
- Molecular formula:
- C56H109N5O C58H113N5O C60H117N5O C62H121N5O
- IUPAC Name:
- e.g. N,N-bis[2-(2-pentadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]hexadecanamide
Constituent 14
- Reference substance name:
- e.g. N-(2-{N-[2-({2-[N-(2-hexadecanamidoethyl)hexadecanamido]ethyl}amino)ethyl]hexadecanamido}ethyl)hexadecanamide
- Molecular formula:
- C72H143N5O4 C74H147N5O4 C76H151N5O4
- IUPAC Name:
- e.g. N-(2-{N-[2-({2-[N-(2-hexadecanamidoethyl)hexadecanamido]ethyl}amino)ethyl]hexadecanamido}ethyl)hexadecanamide
Constituent 15
- Reference substance name:
- e.g. N-{2-[(2-aminoethyl)(hexadecanoyl)amino]ethyl}hexadecanamide
- Molecular formula:
- C36H73N3O2 C38H77N3O2 C40H81N3O2
- IUPAC Name:
- e.g. N-{2-[(2-aminoethyl)(hexadecanoyl)amino]ethyl}hexadecanamide
- State Form:
- other: solid: pellets
Constituent 1
- Reference substance name:
- Not applicable
- Molecular formula:
- not available, unknown constituent
- IUPAC Name:
- Not applicable
Constituent 2
- Reference substance name:
- N-[2-(4-{2-[(2-aminoethyl)amino]ethyl}piperazin-1-yl)ethyl]hexadecanamide N-[2-(4-{2-[(2-aminoethyl)amino]ethyl}piperazin-1-yl)ethyl]octadecanamide
- Molecular formula:
- C26H55N5O C28H59N5O
- IUPAC Name:
- N-[2-(4-{2-[(2-aminoethyl)amino]ethyl}piperazin-1-yl)ethyl]hexadecanamide N-[2-(4-{2-[(2-aminoethyl)amino]ethyl}piperazin-1-yl)ethyl]octadecanamide
Constituent 3
- Reference substance name:
- e.g. N-[2-(4-{2-[(2-hexadecanamidoethyl)amino]ethyl}piperazin-1-yl)ethyl]tetradecanamide
- Molecular formula:
- C40H81N5O2 C42H85N5O2 C44H89N5O2 C46H93N5O2 C48H97N5O2
- IUPAC Name:
- e.g. N-[2-(4-{2-[(2-hexadecanamidoethyl)amino]ethyl}piperazin-1-yl)ethyl]tetradecanamide